Diclofenac Potassium Gel with and without Transcutaneous Electrical Nerve Stimulation in Primary Dysmenorrhea

Effectiveness of Diclofenac Potassium Gel with and without Transcutaneous Electrical Nerve Stimulation in Primary Dysmenorrhea

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241220064105N4

Enrollment

376

Registered

2025-06-02

Start date

2025-01-14

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea. Dysmenorrhea, unspecified

Interventions

Intervention 1: Intervention group: Transcutaneous electrical nerve stimulation (TENS) therapy will be administered alongside diclofenac potassium gel. Transcutaneous electrical nerve stimulation (TEN

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (18-45 years) primary or secondary dysmenorrhea Regular menstrual cycles (21-35days) Moderate to severe menstrual pain Participants were females experiencing PD not using hormonal contraception.

Exclusion criteria

Exclusion criteria: Pregnancy Females with bleeding disorders Breast feeding Uterine fibroids. Adenomyosis Endometriosis Pelvic inflammatory disease Menstrual disorder Hormonal contraceptive use Surgery or Procedures

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: The primary outcome will be measured before the intervention and at 2 and 4 weeks after the intervention. Method of measurement: WALIDD Scale.	—

Countries

Pakistan

Contacts

Public ContactMaliha Khalid Khan

Muhammad Instituite of Medical and Allied Sciences, Multan

malihatareen1997@gmail.com+92 312 6862130

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026